Silence Therapeutics (SLNCF) Current Taxes (2019 - 2024)
Historic Current Taxes for Silence Therapeutics (SLNCF) over the last 6 years, with Q3 2024 value amounting to $8.5 million.
- Silence Therapeutics' Current Taxes rose 297.01% to $8.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $8.5 million, marking a year-over-year increase of 297.01%. This contributed to the annual value of $4486.8 for FY2020, which is 9989.31% down from last year.
- According to the latest figures from Q3 2024, Silence Therapeutics' Current Taxes is $8.5 million, which was up 297.01% from $4.3 million recorded in Q2 2024.
- Silence Therapeutics' Current Taxes' 5-year high stood at $3.6 billion during Q3 2020, with a 5-year trough of $4613.7 in Q4 2020.
- For the 5-year period, Silence Therapeutics' Current Taxes averaged around $564.9 million, with its median value being $5.1 million (2023).
- Within the past 5 years, the most significant YoY rise in Silence Therapeutics' Current Taxes was 15985840.76% (2020), while the steepest drop was 9989.09% (2020).
- Over the past 5 years, Silence Therapeutics' Current Taxes (Quarter) stood at $4613.7 in 2020, then skyrocketed by 138933.97% to $6.4 million in 2021, then increased by 2.74% to $6.6 million in 2022, then increased by 24.72% to $8.2 million in 2023, then grew by 2.97% to $8.5 million in 2024.
- Its Current Taxes stands at $8.5 million for Q3 2024, versus $4.3 million for Q2 2024 and $1.9 million for Q1 2024.